Rescue of human RET gene expression by sodium butyrate: A novel powerful tool for molecular studies in hirschsprung disease

Gut

Volumn 52, Issue 8, 2003, Pages 1154-1158

  Griseri, P ^a   Patrone, G ^a   Puppo, F ^a   Romeo, G ^b   Ravazzolo, R ^a,c   Ceccherini, I ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; PROTEIN RET; TYROSINE KINASE RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HETEROZYGOSITY LOSS; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; MUTATIONAL ANALYSIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; BUTYRATES; DNA, COMPLEMENTARY; GENE EXPRESSION; HIRSCHSPRUNG DISEASE; HUMANS; LOSS OF HETEROZYGOSITY; ONCOGENE PROTEINS; PEDIGREE; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SODIUM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037622910     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.8.1154     Document Type: Article

References (30)

1. Manie S, Santoro M, Fusco A, et al. The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet 2001;17:80-9.
2. Takahashi M, Asai N, Iwashita T, et al. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations. Recent Results Cancer Res 1998;54:229-36.
3. Chakravarti A, Lyonnet S. Hirschsprung disease. In: Scriver CS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, Medical Publishing Division, 2002:6231-55.
4. Wakamatsu N, Yamada Y, Yamada K, et al. Mutations in SIPI, encoding Smad interacting protein 1, cause a form of Hirschsprung disease. Nat Genet 2001;27:369-70.
5. Gabriel SB, Salomon R, Pelet A, et al. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet 2002;31:89-93.
6. Bolk S, Pelet A, Hofstra RMW, et al. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A 2000;97:268-73.
7. Carrasquillo MM, McCallion AS, Puffenberger EG, et al. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 2002;32:237-44.
8. Borrego S, Saez ME, Ruitz A, et al. Specific polymorphisms in the RET proto- oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 1999;65:1469-73.
9. Fitze G, Cramer J, Ziegler A, et al. Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet 2002;359:1200-5.
10. Borrego S, Wright FA, Fernandez RM, et al. A founding locus within the RET proto- oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset or sporadic medullary thyroid carcinoma. Am J Hum Genet 2002;72:88-100.
11. Griseri P, Pesce B, Patrone G, et al. A rare haplotype of the RET proto-oncogene is a risk-modifying allele in Hirschsprung disease. Am J Hum Genet 2002;71:969-74.
12. Teraoka SN, Telatar M, Becker-Catania S, et al. Splicing defects in the ataxia- telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet 1999;64:1617-31.
13. Thomson SA, Wallace MR. RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 2002;110:495-502.
14. Takaya K, Yoshimasa T, Arai H, et al. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin. J Mol Med 1996;74:617-21.
15. Gattei V, Celetti A, Cerrato A, et al. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment. Blood 1997;89:2925-37.
16. Pachnis V, Mankoo B, Costantini F. Expression of the c-RET proto-oncogene during mouse embryogenesis. Development 1993;119:1005-17.
17. Tsuzuki T, Takahashi M, Asai N, et al. Spatial and temporal expression of the RET proto-oncogene product in embryonic, infant and adult rat tissue. Oncogene 1995;10:191-8.
18. Auricchio A, Griseri P, Carpentieri L, et al. Double heterozygosity for a RET substitution interfering with splicing and a EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet 1999;64:1216-21.
19. Griseri P, Sancandi M, Patrone G, et al. Decreased frequency of a single nucleotide polymorphism of the RET proto-oncogene in sporadic Hirschsprung disease. Eur J Hum Genet 2000;8:721-4.
20. Griseri P, Mishto M, Priolo M, et al. An intronic nucleotide variant of the RET proto- oncogene causes Hirschsprung disease by interfering with RNA splicing. Gene Funct Dis 2000;1:184-8.
21. Kaplan JC, Kahn A, Chelly J. Illegitimate transcription: its use in the study of inherited disease. Hum Mutat 1992;1:357-60.
22. Puppo F, Griseri P, Fanelli M, et al. Cell-line specific chromatin acetylation at the Sox10-Pax3 enhancer site modulates the RET proto-oncogene expression. FEBS letters 2002;523:123-7.
23. Ceccherini I, Hofstra R, Luo Y, et al. DNA polymorphisms and conditions for SSCP analysis of the exons of the RET proto-oncogene. Oncogene 1994;9:3025-9.
24. Patrone G, Puppo F, Scaranari M, et al. Cell-line specific transcription rates of the RET gene and functional domains in its minimal promoter. Gene Funct Dis 2000;3:1-8.
25. Takahashi M, Buma Y, Taniguchi M. Identification of the RET proto-oncogene products in neuroblastoma and leukemia cells. Oncogene 1991;6:297-301.
26. Yin L, Ceccherini I, Pasini B, et al. Close linkage with the RET proto-oncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet 1994;2:1803-8.
27. Emerson BM. Specificity of gene regulation. Cell 2002;109:267-70.
28. Krawzczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90:41-54.
29. De Graaf E, Sriniva S, Kilknny C, et al. Differential activities of the RET tyrosine- kinase receptor isoforms during mammalian embryogenesis. Genes Dev 2001;15:2433-44.
30. Tsui-Pierchala BA, Ahrens RC, Crowder RJ, et al.. The long and short isoforms of Ret function as independent signalling complexes. J Biol Chem 2002;277:34618-25.